Lixte Biotechnology Announces a Clinical Trial Agreement with Moffitt Cancer Center to Initiate Phase 1b/2 Trial Evaluating the Safety and Efficacy of LB-100 in Treatment of Patients with Low or Intermediate-1 Risk Myelodysplastic Syndrome Biotech Investing
Onconova Therapeutics Announces Plan for Expanding Rigosertib Clinical Trials for Patients with Myelodysplastic Syndromes (MDS) to South America with Pint Pharma Pharmaceutical Investing
Rexahn Pharmaceuticals Announces Clinical Collaboration with Merck to Evaluate RX-5902 (Supinoxin) in combination with KEYTRUDA (pembrolizumab) for Triple Negative Breast Cancer Pharmaceutical Investing
Approval of Linzess Tablets 0.25 mg in Japan for Additional Indication of Chronic Constipation Pharmaceutical Investing
Can-Fite Announces Enrollment of First Patient in its Comfort Phase III Trial of Piclidenoson in Psoriasis Biotech Investing
Alnylam Completes Enrollment in ENVISION Phase 3 Study of Givosiran, an Investigational RNAi Therapeutic for the Treatment of Acute Hepatic Porphyrias Pharmaceutical Investing
Isodiol International Inc. Enters Hemp Beer and Related Functional Beverage Sector Through Its Subsidiary, IsoBev Cannabis Investing News
European Medicines Agency Authorizes Deferral of Paediatric Investigation Plan for Trogarzo Pharmaceutical Investing
